Distinguishing prostate cancer grades using X-ray and spectroscopic analysis of calcifications

Authors: Sarah Gosling (Keele University) , Emily Arnold (Cranfield University) , Tina Geraki (Diamond Light Source) , Mark Kitchen (Keele University) , Iain Lyburn (Cranfield University; Gloucestershire Hospitals NHS Foundation Trust; Cobalt Medical Charity) , Keith Rogers (Cranfield University) , Tim Snow (Diamond Light Source) , Nicholas Stone (University of Exeter) , Charlene Greenwood (Keele University)
Co-authored by industrial partner: No

Type: Poster

State: Published (Approved)
Published: June 2023

Abstract: Prostate cancer is the most common cancer for men in Europe, accounting for 22 % of all new diagnoses [1]. Diagnosis and prognosis are usually determined with prostate specific antigen (PSA) testing or MRI and/or biopsy but results are often conflicting (in 15-20% of cases), which can lead to over- or undertreatment, causing increased incontinence, impotence and mortality. Identifying robust biomarkers in the prostate tissue microenvironment remains an important investigative avenue for prostate cancer diagnostics and prognostics.

Diamond Keywords: Prostate Cancer

Subject Areas: Medicine, Biology and Bio-materials

Instruments: I18-Microfocus Spectroscopy

Added On: 21/06/2023 12:13

Discipline Tags:

Non-Communicable Diseases Health & Wellbeing Cancer Life Sciences & Biotech

Technical Tags:

Imaging X-ray Fluorescence (XRF)